DK142802B - Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken. - Google Patents
Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken. Download PDFInfo
- Publication number
- DK142802B DK142802B DK97875AA DK97875A DK142802B DK 142802 B DK142802 B DK 142802B DK 97875A A DK97875A A DK 97875AA DK 97875 A DK97875 A DK 97875A DK 142802 B DK142802 B DK 142802B
- Authority
- DK
- Denmark
- Prior art keywords
- stomach
- parts
- coated
- preparation
- gastric juice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2767374 | 1974-03-12 | ||
JP2767374A JPS5512411B2 (es) | 1974-03-12 | 1974-03-12 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK97875A DK97875A (es) | 1975-09-13 |
DK142802B true DK142802B (da) | 1981-02-02 |
DK142802C DK142802C (es) | 1981-09-21 |
Family
ID=12227459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97875AA DK142802B (da) | 1974-03-12 | 1975-03-11 | Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken. |
Country Status (12)
Country | Link |
---|---|
US (1) | US3976764A (es) |
JP (1) | JPS5512411B2 (es) |
BE (1) | BE826498A (es) |
CA (1) | CA1054056A (es) |
CH (1) | CH604719A5 (es) |
DE (1) | DE2510620C2 (es) |
DK (1) | DK142802B (es) |
ES (1) | ES435500A1 (es) |
FR (1) | FR2263744B1 (es) |
GB (1) | GB1507521A (es) |
NL (1) | NL7502952A (es) |
SE (1) | SE409286B (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003437A1 (en) * | 1984-02-10 | 1985-08-15 | A/S Alfred Benzon | Diffusion coated multiple-units dosage form |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
US4207890A (en) * | 1977-01-04 | 1980-06-17 | Mcneilab, Inc. | Drug-dispensing device and method |
JPS6024767B2 (ja) * | 1979-08-24 | 1985-06-14 | 塩野義製薬株式会社 | 腸溶性硬カプセル剤 |
DE3278491D1 (en) * | 1981-07-15 | 1988-06-23 | Key Pharma | Sustained release theophyline |
US4451260A (en) * | 1982-03-26 | 1984-05-29 | Minnesota Mining And Manufacturing Company | Sustained release oral medicinal delivery device |
JPS5953410A (ja) * | 1982-09-20 | 1984-03-28 | Fujisawa Pharmaceut Co Ltd | 新型ソフトカプセル剤 |
JPS59193831A (ja) * | 1983-04-18 | 1984-11-02 | Sankyo Co Ltd | 腸溶性製剤の製造法 |
US4505890A (en) * | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
JPS61107782U (es) * | 1984-12-19 | 1986-07-08 | ||
US4735804A (en) * | 1985-05-10 | 1988-04-05 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4758436A (en) * | 1985-05-29 | 1988-07-19 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4767627A (en) * | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US4666705A (en) * | 1985-06-03 | 1987-05-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4756911A (en) * | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
DE3803482A1 (de) * | 1988-02-05 | 1989-08-17 | Lohmann Therapie Syst Lts | Schwimmfaehiges orales therapeutisches system |
JPH082781B2 (ja) * | 1988-10-18 | 1996-01-17 | 嘉明 川島 | 中空顆粒状医薬及びその製法 |
AU654143B2 (en) * | 1990-06-25 | 1994-10-27 | Du Pont Merck Pharmaceutical Company, The | Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
US5198229A (en) * | 1991-06-05 | 1993-03-30 | Alza Corporation | Self-retaining gastrointestinal delivery device |
US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
JP2671257B2 (ja) * | 1995-07-13 | 1997-10-29 | エーザイ株式会社 | 溶解遅延性ゼラチン製剤組成物 |
SE9702533D0 (sv) | 1997-07-01 | 1997-07-01 | Astra Ab | New oral formulation |
IN186245B (es) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
JP4523153B2 (ja) | 1998-03-19 | 2010-08-11 | ブリストル−マイヤーズ スクイブ カンパニー | 易溶性薬物の二層性放出制御送達システムおよび方法 |
EP1245227A1 (en) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
US20030203027A1 (en) * | 2002-04-26 | 2003-10-30 | Ethicon, Inc. | Coating technique for deposition of drug substance on a substrate |
US20040086566A1 (en) * | 2002-11-04 | 2004-05-06 | Alpharma, Inc. | Waxy matrix dosage forms |
US7485322B2 (en) * | 2002-12-24 | 2009-02-03 | Lek Pharmaceuticals D.D. | Modified release pharmaceutical composition |
CA2516327C (en) * | 2003-02-21 | 2012-04-17 | Lek Pharmaceuticals D.D | Therapeutic system comprising amoxicillin and clavulanic acid |
US20060210625A1 (en) * | 2003-11-04 | 2006-09-21 | Shire Laboratories, Inc. | Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
KR20090065524A (ko) * | 2006-09-04 | 2009-06-22 | 파나세아 바이오테크 리미티드 | 프로그래머블 부력전달기술 |
WO2009087665A2 (en) * | 2007-12-11 | 2009-07-16 | Vishwanath Sudhir Nande | Novel gastroretentive drug delivery system |
GB2462022B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
KR20110042366A (ko) * | 2008-08-18 | 2011-04-26 | 팀 아카데미 오브 파마슈티컬 사이언스 | 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용 |
FR2945947B1 (fr) | 2009-05-29 | 2011-07-29 | Flamel Tech Sa | Compositions pharmaceutiques flottantes a liberation controlee |
FR2945945B1 (fr) * | 2009-05-29 | 2011-07-29 | Flamel Tech Sa | Procede de preparation de particules creuses et leurs applications |
EP2457561A4 (en) * | 2009-07-06 | 2014-03-05 | Kyorin Seiyaku Kk | TABLET HAVING A HOLLOW STRUCTURE |
CA2803064C (en) | 2010-07-05 | 2017-12-19 | Jagotec Ag | Dosage form |
BR112014000773A8 (pt) * | 2011-07-14 | 2017-10-03 | Apet Holding B V | Composições de nicotinamida e uso terapêutico das mesmas |
AU2012322323B2 (en) | 2011-10-11 | 2016-04-21 | Sun Pharmaceutical Industries Limited | A gastroretentive dosage system and process of preparation thereof |
AU2013290875A1 (en) * | 2012-07-16 | 2015-02-05 | APET Holding B.V. | Gastro-retentive drug delivery system |
RS54024B1 (en) | 2012-10-12 | 2015-10-30 | Omya International Ag | GASTRORETENCY FORMULATION OF MEDICINES AND SYSTEMS FOR DELIVERY AND METHODS OF THEIR PREPARATION USING FUNCTIONALIZED CALCIUM CARBONATE |
US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
BR122021018078B1 (pt) | 2014-06-11 | 2022-02-08 | Massachusetts Institute Of Technology | Artigo e estrutura de residência gástrica |
EP3034070A1 (en) | 2014-12-18 | 2016-06-22 | Omya International AG | Method for the production of a pharmaceutical delivery system |
EP3069713A1 (en) | 2015-03-20 | 2016-09-21 | Omya International AG | Dispersible dosage form |
CN104706613B (zh) * | 2015-03-20 | 2018-01-16 | 华侨大学 | 一种胃漂浮空心缓释片的制备方法 |
JP2018515476A (ja) | 2015-05-01 | 2018-06-14 | マサチューセッツ インスティテュート オブ テクノロジー | 誘発性形状記憶誘導デバイス |
US11576859B2 (en) | 2015-10-23 | 2023-02-14 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
CA3007633A1 (en) | 2015-12-08 | 2017-06-15 | Lyndra, Inc. | Geometric configurations for gastric residence systems |
AU2017235598A1 (en) * | 2016-03-18 | 2018-08-09 | Grünenthal GmbH | Floating pharmaceutical dosage form |
EP3269361A1 (en) | 2016-07-14 | 2018-01-17 | Omya International AG | Dosage form |
CA3038557A1 (en) | 2016-09-30 | 2018-04-05 | Lyndra, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
CN110996906A (zh) | 2017-06-09 | 2020-04-10 | 林德拉有限公司 | 具有调节释放速度的膜的胃驻留系统 |
US20230009115A1 (en) * | 2020-03-02 | 2023-01-12 | Craft Health Pte Ltd | Oral dosage forms for extended drug release |
WO2023166225A1 (en) * | 2022-03-04 | 2023-09-07 | APET Holding B.V. | Digestive enzyme formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3418999A (en) * | 1964-02-12 | 1968-12-31 | Donald W. Davis | Method of swallowing a pill |
FR1454013A (fr) * | 1965-08-18 | 1966-07-22 | Pluripharm | Mode de présentation de deux médicaments associés |
US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
-
1974
- 1974-03-12 JP JP2767374A patent/JPS5512411B2/ja not_active Expired
-
1975
- 1975-03-10 FR FR7507336A patent/FR2263744B1/fr not_active Expired
- 1975-03-10 BE BE154189A patent/BE826498A/xx not_active IP Right Cessation
- 1975-03-11 DE DE2510620A patent/DE2510620C2/de not_active Expired
- 1975-03-11 SE SE7502725A patent/SE409286B/xx not_active IP Right Cessation
- 1975-03-11 US US05/557,408 patent/US3976764A/en not_active Expired - Lifetime
- 1975-03-11 DK DK97875AA patent/DK142802B/da not_active IP Right Cessation
- 1975-03-11 ES ES435500A patent/ES435500A1/es not_active Expired
- 1975-03-12 GB GB10214/75A patent/GB1507521A/en not_active Expired
- 1975-03-12 CA CA221,903A patent/CA1054056A/en not_active Expired
- 1975-03-12 NL NL7502952A patent/NL7502952A/xx not_active Application Discontinuation
- 1975-03-12 CH CH315475A patent/CH604719A5/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003437A1 (en) * | 1984-02-10 | 1985-08-15 | A/S Alfred Benzon | Diffusion coated multiple-units dosage form |
Also Published As
Publication number | Publication date |
---|---|
DE2510620C2 (de) | 1984-01-05 |
NL7502952A (nl) | 1975-09-16 |
JPS5512411B2 (es) | 1980-04-02 |
DE2510620A1 (de) | 1975-09-18 |
JPS50121418A (es) | 1975-09-23 |
GB1507521A (en) | 1978-04-19 |
US3976764A (en) | 1976-08-24 |
CA1054056A (en) | 1979-05-08 |
FR2263744B1 (es) | 1978-11-24 |
ES435500A1 (es) | 1977-02-01 |
SE409286B (sv) | 1979-08-13 |
DK142802C (es) | 1981-09-21 |
BE826498A (fr) | 1975-06-30 |
CH604719A5 (es) | 1978-09-15 |
DK97875A (es) | 1975-09-13 |
FR2263744A1 (es) | 1975-10-10 |
SE7502725L (es) | 1975-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK142802B (da) | Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken. | |
US5540945A (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
EP0235718B1 (en) | Granule remaining in stomach | |
FI78835C (fi) | Foerfarande foer framstaellning av en ny dipyridamol-retardform. | |
US2928770A (en) | Sustained action pill | |
CA2342340C (en) | New sustained release oral formulations | |
BE1004882A3 (fr) | Forme posologique pharmaceutique solide orale a liberation programmee. | |
RU2477126C2 (ru) | Глюкозинолаты и бета-тиоглюкозидазы, покрытые энтеросолюбильной оболочкой | |
US4587118A (en) | Dry sustained release theophylline oral formulation | |
RU2095054C1 (ru) | Твердая лекарственная форма для орального введения | |
BG63152B1 (bg) | Дозирани форми с контролирано освобождаване на азитромицин | |
AU2018202652A1 (en) | Gastro-retentive drug delivery system | |
AU783911B2 (en) | Coated solid dosage forms | |
GB2101484A (en) | Oral dipyridamole compositions | |
DK151608B (da) | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse | |
PL188834B1 (pl) | Farmaceutyczne formulacje zawierające tramadol lub jego fizjologicznie akceptowane sole oraz sposóbwytwarzania tych formulacji | |
JPH0256418A (ja) | 新規医薬製剤およびその製造方法 | |
JPS5859916A (ja) | ブロモヘキシンの遅延放出剤型およびその製造方法 | |
Gohel | Modulation of active pharmaceutical material release from a novel ‘tablet in capsule system’containing an effervescent blend | |
EP0425699B1 (en) | Oral preparation which can be released at suitable region in intestine | |
JPH0624962A (ja) | 腸溶徐放性製剤 | |
CN105377247A (zh) | 用于治疗溃疡性结肠炎含磷脂酰胆碱的药物制剂 | |
WO2020060426A1 (en) | An oral preparation containing sodium butyrate | |
AU684786B2 (en) | A drug delivery composition for alpha-adreno receptor blocking agents | |
CA2644699A1 (en) | Oral pharmaceutical coated composition for pulsatile release |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |